BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026

  February 6, 2026

   · 

  1 min read
• Press Releases

  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update

  February 6, 2026

   · 

  1 min read
• Press Releases

  Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March 2026

  February 6, 2026

   · 

  2 min read
• Press Releases

  ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences in February 2026

  February 6, 2026

   · 

  1 min read
• Press Releases

  Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

  February 6, 2026

   · 

  1 min read
• Press Releases

  Coeptis Receives Shareholder Approval Towards Z Squared Merger

  February 6, 2026

   · 

  5 min read
• Press Releases

  Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026

  February 6, 2026

   · 

  2 min read
• Press Releases

  Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

  February 6, 2026

   · 

  12 min read
• Press Releases

  Long-Term Data Presented at the 22nd Annual WORLDSymposium™ Highlights Tralesinidase Alfa Enzyme Replacement Therapy’s Potential as the First Disease-Modifying Treatment Option for Sanfilippo Syndrome Type B (MPS IIIB)

  February 6, 2026

   · 

  9 min read
• Press Releases

  Bruker Announces Quarterly Preferred Stock Dividend

  February 6, 2026

   · 

  2 min read